In the CD335 ESMA CAR-treated tumor core and border, a more pronounced cytoskeletal structure characterized by higher cytokeratin 7 (CK7) and SMA expression compared to the outer tumor region could be observed (Figure 5b). The gene discussed is NCR1; the disease is neoplasm.